VYOME HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
VYOME HOLDINGS, INC. (HIND) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 129 shares for the 12-month period ending 2024-12-31, per its 10-Q filed 2025-11-14.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-11-14
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-12-31 was -790.00K shares, a 1120.25% decline year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-09-30 was 327.00K shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-06-30 was 436.00K shares, a 118.00% increase year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-03-31 was 27.00K shares, a 96.71% decline year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 237.20K shares, a 85.54% decline from fiscal 2018.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 1.64M shares, a 76.15% increase from fiscal 2017.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 931.34K shares, a 47.90% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | 129.00 shares 10-Q · filed 2025-11-14 | 131.00 shares 8-K · filed 2025-09-02 | |||
| 2020-12-31 | -790.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -463.00K shares derived: sum of 2 quarters · filed 2022-04-08 | -27.00K shares derived: sum of 3 quarters · filed 2022-04-08 | 0.00 shares 10-K · filed 2022-04-08 | 790.00K shares 10-K · filed 2021-03-12 |
| 2020-09-30 | 327.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 763.00K shares derived: sum of 2 quarters · filed 2020-11-06 | 790.00K shares 10-Q · filed 2020-11-06 | 867.43K shares derived: sum of 4 quarters · filed 2020-11-06 | |
| 2020-06-30 | 436.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | 463.00K shares 10-Q · filed 2020-07-30 | 540.43K shares derived: sum of 3 quarters · filed 2020-07-30 | -319.42K shares derived: sum of 4 quarters · filed 2020-07-30 | |
| 2020-03-31 | 27.00K shares 10-Q · filed 2020-06-19 | 104.43K shares derived: sum of 2 quarters · filed 2020-06-19 | -755.42K shares derived: sum of 3 quarters · filed 2020-06-19 | -555.42K shares derived: sum of 4 quarters · filed 2020-06-19 | |
| 2019-12-31 | 77.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -782.42K shares derived: sum of 2 quarters · filed 2020-02-27 | -582.42K shares derived: sum of 3 quarters · filed 2020-02-27 | 237.20K shares 10-K · filed 2020-02-27 | |
| 2019-09-30 | -859.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -659.85K shares derived: sum of 2 quarters · filed 2019-11-08 | 159.76K shares 10-Q · filed 2019-11-08 | 234.49K shares derived: sum of 4 quarters · filed 2019-11-08 | |
| 2019-06-30 | 200.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | 1.02M shares 10-Q · filed 2019-07-24 | 1.09M shares derived: sum of 3 quarters · filed 2019-07-24 | 1.13M shares derived: sum of 4 quarters · filed 2019-07-24 | |
| 2019-03-31 | 819.62K shares 10-Q · filed 2019-05-10 | 894.34K shares derived: sum of 2 quarters · filed 2019-05-10 | 926.13K shares derived: sum of 3 quarters · filed 2019-05-10 | 1.66M shares derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-12-31 | 74.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 106.51K shares derived: sum of 2 quarters · filed 2019-02-22 | 840.06K shares derived: sum of 3 quarters · filed 2019-02-22 | 1.64M shares 10-K · filed 2019-02-22 | |
| 2018-09-30 | 31.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | 765.33K shares derived: sum of 2 quarters · filed 2018-11-02 | 1.57M shares 10-Q · filed 2018-11-02 | 1.60M shares derived: sum of 4 quarters · filed 2018-11-02 | |
| 2018-06-30 | 733.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 1.53M shares 10-Q · filed 2018-08-02 | 1.57M shares derived: sum of 3 quarters · filed 2018-08-02 | 1.92M shares derived: sum of 4 quarters · filed 2018-08-02 | |
| 2018-03-31 | 800.53K shares 10-Q · filed 2018-05-10 | 838.11K shares derived: sum of 2 quarters · filed 2018-05-10 | 1.18M shares derived: sum of 3 quarters · filed 2018-05-10 | 1.54M shares derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-12-31 | 37.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | 381.51K shares derived: sum of 2 quarters · filed 2018-03-05 | 742.39K shares derived: sum of 3 quarters · filed 2018-03-05 | 931.34K shares 10-K · filed 2018-03-05 | |
| 2017-09-30 | 343.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 704.81K shares derived: sum of 2 quarters · filed 2017-11-03 | 893.77K shares 10-Q · filed 2017-11-03 | 1.94M shares derived: sum of 4 quarters · filed 2017-11-03 | |
| 2017-06-30 | 360.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 549.83K shares 10-Q · filed 2017-08-02 | 1.60M shares derived: sum of 3 quarters · filed 2017-08-02 | ||
| 2017-03-31 | 188.96K shares 10-Q · filed 2017-05-10 | 1.24M shares derived: sum of 2 quarters · filed 2017-05-10 | |||
| 2016-12-31 | 1.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 1.79M shares 10-K · filed 2017-02-23 | |||
| 2016-09-30 | 740.78K shares 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |